Tradestie Institutional Equity Comparison Engine

KALV vs CRMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KALV Overall Edge

KALV Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to KalVista Pharmaceuticals, Inc. Common Stock (KALV) driven by superior Momentum & Technical, Options & Structure while CRMD counters with relative strength in Valuation, Growth & Margin. Fundamentally, KALV trades at 25.4x Forward P/E with -57.4% operating margin (+30.7% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, KALV sits in UNCLASSIFIED (31st %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CRMD
KALV 25.4x vs CRMD 49.0x Fwd P/E
Growth & Margin Winner CRMD
Op Margin -57.4% vs 41.0% ยท YoY +30.7% vs -47.7%
Momentum & Technical Winner KALV
1Y +82.9% vs -56.2% ยท 52W Pos 100% vs 3%
Options & Structure Winner KALV
UNCLASSIFIED (31st %ile IV) vs BREAKDOWN (25th %ile IV)
KALV NASDAQ
KalVista Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$27.00
+0.04% 1D
Market Cap $1.4B
1M Return +1.09%
1Y Return +82.93%
Forward P/E 25.4x
Unified AI Score
55.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 57.0 Mom 40.0
CRMD NASDAQ
CorMedix Inc.
Pharmaceutical Preparations
$4.92
+5.47% 1D
Market Cap $384.7M
1M Return -32.3%
1Y Return -56.16%
Forward P/E 49.0x
Unified AI Score
53.2 / 100 HOLD
Tech 60.0 Fund 60.0 Flow 69.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KALV +82.93% CRMD -56.16% Spread: +128.03 pp (KALV Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
KALV TTM Op. Margin: -57.4% CRMD TTM Op. Margin: 41.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KALV vs CRMD. Trailing 12-month operating profitability (KALV -57.4% vs CRMD 41.0%) and valuation multiples (KALV 25.4x vs CRMD 49.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KALV (6) vs CRMD (4)
Institutional Metric KALV CRMD Criterion Row Winner
Market Capitalization Scale $1.4B $384.7M Larger Scale KALV
Trailing P/E Ratio Valuation 25.4x 2.4x Lower Multiple CRMD
Forward P/E Ratio Valuation 25.4x 49.0x Lower Multiple KALV
Revenue Growth (YoY) Growth +30.7% -47.7% Higher Growth KALV
Operating Margin (TTM) Profitability -57.4% 41.0% Higher Margin CRMD
Net Profit Margin Profitability -118.7% 15.5% Higher Margin CRMD
Return on Equity (ROE) Capital Efficiency -190.2% 15.3% Higher ROE CRMD
52-Week Range Position Momentum 100% ($10โ€“$27) 3% ($5โ€“$13) Stronger Trend KALV
Beta / 30D Volatility Risk Regime 0.85ฮฒ ยท 2% Vol 1.20ฮฒ ยท 107% Vol Lower Realized Risk KALV
Unified Institutional Score Composite Signal 55.1 / 100 (HOLD) 53.2 / 100 (HOLD) Higher Composite KALV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KALV vs CRMD Buy Guide
KALV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live KALV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CRMD BREAKDOWN
109d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live CRMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KALV nor CRMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.